Serotonin transporter gene and schizophrenia: Evidence for association/linkage disequilibrium in families with affected siblings

Molecular Psychiatry

Volumn 5, Issue 1, 2000, Pages 91-95

  Hranilovic, D ^a   Schwab, S G ^b   Jernej, B ^a   Knapp, M ^b   Lerer, B ^c   Albus, M ^d   Rietschel, M ^b   Kanyas, K ^c   Borrmann, M ^d   Lichtermann, D ^b   Maier, W ^b   Wildenauer, D B ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF BONN   (Germany)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d KLINIKUM MÜNCHEN OST   (Germany)

Author keywords

5 HTT; Intron; Polymorphism; Promoter; Schizophrenia; TDT

Indexed keywords

SEROTONIN TRANSPORTER;

ARTICLE; DNA POLYMORPHISM; FAMILY STUDY; GENE LINKAGE DISEQUILIBRIUM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOIDISM; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SIBLING; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0033966436     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000599     Document Type: Article

References (43)

1. 1 Lesch KP, Moessner R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry 1998; 44: 179-192.
2. 2 Owens MJ, Nemeroff CB. The role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994; 40: 288-295.
3. 3 Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK et al. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Arch Gen Psychiatry 1993; 50: 624-635.
4. 4 Meltzer HZ. Clozapine and other atypical neuroleptics: efficacy, side effects, optimal utilization. J Clin Psychiat 1994; 12: 38-42.
5. 5 Roth BL, Ciaranello RD, Meltzer HZ. Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. J Pharmacol Exp Ther 1992; 260: 1361-1365.
6. 6 Watling KJ, Beer MS, Stanston JA, Newberry NR. Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat. Eur J Pharmacol 1990; 182: 465-472.
7. 7 Joyce JN, Shane A, Lexov N, Winokur A, Casanova MF, Kleinman JE. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 1993; 8: 315-336.
8. 8 Naylor L, Dean B, Opeskin K, Pavey G, Hill G, Keks N et al. Changes in serotonin transporter in the hippocampus of subjects with schizophrenia identified using (3H) paroxetine. J Neural Transm Gen Sect 1996; 103: 749-757.
9. 9 Hernandez I, Sokolov BP. Abnormal expression of serotonin transporter mRNA in the frontal and temporal cortex of schizophrenics. Mol Psychiatry 1997; 2: 57-64.
10. 10 Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL et al. Organization of human serotonin transporter gene. J Neural Transm Gen Sect 1994; 95: 157-164.
11. 11 Heils A, Teufel A, Petri S, Seemann M, Bengel D, Balling U et al. Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J Neural Transm Gen Sect 1995; 102: 247-254.
12. 12 Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
13. 13 Bonnet-Brilhault F, Laurent C, Thibaut F, Campion D, Chavand O, Samolyk D et al. Serotonin transporter gene polymorphism and schizophrenia: an association study. Biol Psychiatry 1997; 42: 634-636.
14. 14 Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D. A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol Psychiatry 1998; 3: 328-332.
15. 15 Mendes De Oliveira JR, Otto PA, Vallada H, Lauriano V, Elkis H, Lafer B et al. Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia. Am J Med Genet 1998; 81: 225-227.
16. 16 Rao D, Joensson EG, Paus S, Ganguli R, Noethen M, Nimgaonkar VL. Schizophrenia and the serotonin transporter gene. Psychiatr Genet 1998; 8: 207-212.
17. 17 Stoeber G, Jatzke S, Heils A, Jungkunz G, Fuchs E, Knapp M et al. Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene. Eur Arch Psychiatry Clin Neurosci 1998; 248: 82-86.
18. 18 Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwin GM et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996; 347: 731-733.
19. 19 Stoeber G, Heils A, Lesch KP. Serotonin transporter gene polymorphism and affective disorder. Lancet 1996; 347: 1340-1341.
20. 20 Collier DA, Arranz MJ, Sham P, Battersby S, Gill P, Aitchison KJ et al. A VNTR in the serotonin transporter gene is a potential susceptibility factor for bipolar affective disorder. Neuroreport 1996; 7: 1675-1679.
21. 21 Rees M, Norton N, Jones I, McCndless F, Scourfield J, Holmans P et al. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Mol Psychiatry 1997; 2: 398-402.
22. 22 Kunugi H, Hattori M, Kalo T, Tatsumi M, Sakai T, Sasaki T et al. Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Mol Psychiatry 1997; 2: 457-462.
23. 23 Collier DA, Stoeber G, Li T, Heils A, Catalano M, Di Bella D et al. A novel functional plymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1996; 1: 453-460.
24. 24 Furlong RA, Ho L, Walsh C, Rubinsztein JS, Jain S, Paykel ES et al. Analysis and meta-analysis of two serotonin transporter gene polymorphisms in bipolar and unipolar affective disorders. Am J Med Genet 1998; 81: 58-63.
25. 25 Ball D, Hill L, Freemann B, Eley TC, Strelau J, Reimann R et al. The serotonin transporter gene and peer-rated neuroticism. Neuroreport 1997; 8: 1301-1304.
26. 26 Hoehe M, Wendel B, Grunewald I, Chiaroni P, Levy N, Morris-Rosendahl D et al. Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders. Am J Med Genet 1998; 81: 1-3.
27. 27 Jorm AF, Henderson AS, Jacomb PA, Christiansen H, Korten AE, Rodgers B et al. An association study of a functional polymorphism of the serotonin transporter gene with personality and psychiatric symptoms. Mol Psychiatry 1998; 3: 449-451.
28. 28 Esterling LE, Yoshikawa T, Turner G, Badner JA, Bengel D, Gershon ES et al. Serotonin transporter (5-HTT) gene and bipolar affective disorder. Am J Med Genet 1998; 81: 37-40.
29. 29 Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
30. 30 Spielman RS, Ewens WJ. Invited Editorial: The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59: 983-989.
31. 31 Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Hoenig S et al. Support for a locus on chromosome 18p conferring susceptibility to functional psychosis in families with schizophrenia by association and linkage analysis. Am J Hum Genet 1998; 63: 1139-1152.
32. 32 Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger JI et al. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci USA 1994; 91: 5918-5921.
33. 33 Stine OC, Xu J, Koskela R, McMahon FJ. Gschwend M, Friddle C et al. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. Am J Hum Genet 1995; 57: 1384-1394.
34. 34 Schwab SG, Hallmayer J, Albus M, Lerer B, Hanses C, Kanyas K et al. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet 1998; 81: 302-307.
35. 35 Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B et al. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millenium Consortium. Am J Med Genet 1998; 81: 290-295.
36. 36 Straub RE, MacLean CJ, Martin RB, Ma Y, Myakishev MV, Harris-Kerr C et al. A schizophrenia locus may be located in region 10p15-p11. Am J Med Genet 1998; 81: 296-301.
37. 37 Rice JP, Goate A, Williams JT, Bierut L, Dorr D, Wu W et al. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 1, 6, 8, 10 and 12. Am J Med Genet 1997; 74: 247-253.
38. 38 Levinson DF, Coon H. Chromosome 22 workshop. Psychiatric Genet 1998; 8: 115-120.
39. 39 Bennet ST, Lucassen AM, Gough SCL et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin mini-satellite locus. Nature Genet 1995; 9: 284-292.
40. 40 Abel L, Müller-Mysok B. Maximum-likelihood expression of the transmission/disequilibrium test and power considerations. Am J Hum Genet 1998; 63: 664-667.
41. 41 Spitzer RL, Williams JB. Structured Clinical Interview for DSM-III Diagnoses - Personality Disorders. New York State Psychiatric Institute: New York, 1985.
42. 42 McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991; 48: 764-770.
43. 43 Morris AP, Curnow RN, Whittaker JC. Randomization tests of disease-marker associations. Ann Hum Genet 1997; 61: 49-60.